Protective role of Momordica charantia seeds extract on membrane bound ATPases and lysosomal hydrolases in rats with streptozotocin diabetes

Journal of Plant Sciences

Volumn 2, Issue 3, 2007, Pages 293-301

  Sathishsekar, D ^a,b   Rajasekaran, S ^a  

^a UNIVERSITY OF MADRAS   (India)

^b NONE   (India)

Author keywords

Aqueous extract; Lysosomal hydrolases; Membrane bound ATPases; Momordica charantia; Streptozotocin induced diabetes

Indexed keywords

MOMORDICA CHARANTIA; RATTUS;

EID: 34548785681     PISSN: 18164951     EISSN: None     Source Type: Journal    
DOI: 10.3923/jps.2007.293.301     Document Type: Article

References (44)

1. Aubier, M. and N. Viires, 1998. Calcium ATPase and respiratory muscle functions. Eur. Respir. J., 11:758-766.
2. Baynes, J.W., 1991. Role of oxidative stress in development of complications in diabetes. Diabetes, 40: 405-412.
3. Belfiore, F., A.M. Rabuazzo, R. Iannello, Campione and D. Vasta, 1986. Anabolic response of some tissues to diabetes. Biochem. Med. Meta. Biol., 35: 149-155.
4. Beisswenger, P.G. and R.G. Spiro, 1970. Human glomerular basement membrane: Chemical alteration in diabetes mellitus. Science, 168: 596-598.
5. Bironaite, D. and K. Ollinger, 1997. The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem. Biol. Inter., 103: 35-50.
6. Bonting, S.L., 1970. Biobehavioural Base of Coronary Heart Disease. In: Membrane and Ion Transport Dembroski, T.M., T.H. Schmidt and G. Blumchen (Eds.), Vol. 1, Wiley Inter Science, London, pp: 254-363.
7. Brasitus, T.A. and P.K. Dudeja, 1985. Conection of abnormal lipid fluidity and composition of rat ileal microvillus membranes in chronic streptozotocin-induced diabetes by insulin therapy. J. Biol. Chem., 260: 12405-12409.
8. Conchie, J., A.L. Gelman and G.A. Levry, 1967. Inhibition of glycosidases by aldonolactones of corresponding configuration. The C-4 and C-6 specificity of beta-glucosidase and beta-galactosidase. Biochem. J., 103: 609-615.
9. Evans, D.J., 1969. Membrane adenosine triphosphatase of Escherichia coli: Activation by calcium ion and inhibition by monovalent cations. J. Bacteriol., 100: 914-916.
10. +) ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia, 29: 623-628.
11. Fushimi, H. and S. Tarui, 1974. Kidney and serum beta-N- acetylglucosaminidase activities in streptozotocin diabetic rats and their responses to insulin and glucagon. J. Biochem. (Tokyo), 76: 225-227.
12. Geetha, R., 1993. Effect of tocopherol on doxorubicin induced changes in rat heart lysosomal enzymes. Ind. J. Exp. Biol., 31: 288-290.
13. Giugliano, D., A. Ceriello and G. Paolisso, 1996. Oxidative stress and diabetic vascular complications. Diabetes Care, 193: 257-267.
14. 2+-ATPase from erythrocyte membranes. Biochem. Biophys. Acta, 728: 281-288.
15. Hokins, L.E., J.L. Dhal, J.D. Deupree, K.F. Dixon, J.F. Hackney and J.E. Perduce, 1973. Studies on the characterization of the sodium potassium transport adenosine triphosphatase. J. Biol. Chem., 248: 2593-2605.
16. Hultberg, B., J. Linsten and S. Sjoblad, 1976. Molecular form and activities of glycosidases in culture amniotic fluid. Biochem. J., 155: 599-605.
17. Jayasooriya, A.P., M. Sakono, C. Yuxizaki, M. Kawano, K. Yanmoto and N. Fukuda, 2000. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J. Etanopharmacol., 72: 331.
18. Jensen, T., S. Stender and T. Deckert, 1988. Abnormalities in plasma concentrations of lipoprotein and fibrinogen in type1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia, 31: 142-145.
19. Jourdheuil, D.R., Y. Mourayre, P. Vague, J. Boyer and I. Juhan-Vague, 1987. In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics. Diabetes, 36: 991-995.
20. Kelly, L. and S.H. Woodward, 1988. Alterations in the activities of lysosomal glycosidases in human diabetes. Med. Sci. Res., 16: 491-496.
21. King, J., 1965. The Hydrolases-acid and Alkaline Phosphatases. In: Practical Clin. Enzymol. Van, D. (Ed.), Nostran Co, London, pp: 191-208.
22. 2+) adenosine triphosphatase activity in kidney membranes from streptozotocin non-insulin dependent diabetic rats. Metabolism, 43: 604-613.
23. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with Fohn-phenol reagent. J. Biol. Chem., 193: 265-275.
24. McCune, L.M. and T. Johns, 2002. Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the north american boreal forest. J. Ethnopharmacol., 82: 197-205.
25. Moore, J.C. and J.E. Morris, 1982. A simple automated colorimetric method for determination of N-acetyl-β-D-glucosaminidase. Ann. Clin. Biochem., 19: 157-159.
26. Nerurkar, M.A., J.G. Satav and S.S. Katyare, 1988. Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia, 31: 119-122.
27. Oberley, L.W., 1988. Free radicals and diabetes. Free Radic. Biol. Med., 5: 113-118.
28. 2+-ATPase activities in normal, regenerating and malignant cells. Biochem. Biophys. Acta, 684: 67-74.
29. Olsen, I., S. Bon-Gharios and D. Abraham, 1990. The activation of resting lymphocytes is accompanied by the biogenesis of lysosomal organelles. Eur. J. Immunol., 20: 2161-2170.
30. Osicka, T.M., Z. Kiriazis, L.M. Pratt, G. Jerums and W.D. Comper, 2001. Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia, 44: 230-236.
31. Parinandi, N.L., E.D.W. Thompson and H.O.H. Schmid, 1990. Diabetes heart and kidney exhibit increased resistance to lipid peroxidation. Biochem. Biophys. Acta, 1047: 63-69.
32. Rakieten, N., M.L. Rakieten and M.V. Nadkarni, 1963. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cane Chemo. Ther. Rep., 29: 91-98.
33. Ramanadevi, C.h.V., M. Hemaprasad, T. Padmajareddy and P.P. Reddy, 1997. Glycosylation of hemoglobin and erythrocyte membrane proteins mediated changes inosmotic fragility of erythrocytes. Ind. J. Med. Sci., 51: 5-9.
34. Sapolsky, A.L., R.D. Airman and D.S. Howell, 1973. Cathepsin-D activity in normal and osteoarthritic human cartilage. Fedn. Proc., 32: 1489-1493.
35. Sasaki, T., S. Matsy and A. Sonae, 1972. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku, 1: 346-353.
36. Sathishsekar, D., K. Sivagnanam and S. Subramanian, 2005. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats. Pharmazie, 60: 383-387.
37. Sathishsekar, D. and S. Subramanian, 2005a. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol. Pharm. Bull., 28: 978-983.
38. Sathishsekar, D. and S. Subramanian, 2005b. Antioxidant properties of Momordica charantia seeds on streptozotocin induced diabetic rats. Asia Pacific J. Clin. Nutr., 14: 153-158.
39. Sathishsekar, D. and S. Subramanian, 2006. Hypolipidemic effect of Momordica charantia seeds extract on streptozotocin-induced diabetic rats. J. Nat. Rem., 6: 41-52.
40. +-ATPase. Pak. J. Biol. Sci., 6: 1971-1975.
41. +-ATPase by insulin: Why and how? Mol. Cell. Biochem., 182: 121-133.
42. +-ATPase: Sensitivity to membrane lipid peroxidation and the protective effect of vitamin E. Arch. Biochem. Biophys., 281: 96-105.
43. Wattiaux, R., 1977. Mammalian Cell Membrane. Jamieson, G.A. and D.M. Robinson (Eds.), 2nd Edn. Butterworrh, London, pp: 165.
44. Witek, B., T. Krol, A. Kolataj, E. Ochwanowska, I. Stanislawska and A. Sewa, 2001. The insulin, glucose and cholesterol level and activity of lysosomal enzymes in the course of the model alloxan diabetes. Neuroendocrinol. Lett., 22: 238-242.